Cargando…
Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study)
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733017/ https://www.ncbi.nlm.nih.gov/pubmed/36482439 http://dx.doi.org/10.1186/s12916-022-02695-5 |
| _version_ | 1784846261455683584 |
|---|---|
| author | Kinoshita, Taku Shinoda, Masahiro Nishizaki, Yasuhiro Shiraki, Katsuya Hirai, Yuji Kichikawa, Yoshiko Tsushima, Kenji Shinkai, Masaharu Komura, Naoyuki Yoshida, Kazuo Kido, Yasutoshi Kakeya, Hiroshi Uemura, Naoto Kadota, Junichi |
| author_facet | Kinoshita, Taku Shinoda, Masahiro Nishizaki, Yasuhiro Shiraki, Katsuya Hirai, Yuji Kichikawa, Yoshiko Tsushima, Kenji Shinkai, Masaharu Komura, Naoyuki Yoshida, Kazuo Kido, Yasutoshi Kakeya, Hiroshi Uemura, Naoto Kadota, Junichi |
| author_sort | Kinoshita, Taku |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9733017 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | BioMed Central |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-97330172022-12-10 Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) Kinoshita, Taku Shinoda, Masahiro Nishizaki, Yasuhiro Shiraki, Katsuya Hirai, Yuji Kichikawa, Yoshiko Tsushima, Kenji Shinkai, Masaharu Komura, Naoyuki Yoshida, Kazuo Kido, Yasutoshi Kakeya, Hiroshi Uemura, Naoto Kadota, Junichi BMC Med Correction BioMed Central 2022-12-08 /pmc/articles/PMC9733017/ /pubmed/36482439 http://dx.doi.org/10.1186/s12916-022-02695-5 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
| spellingShingle | Correction Kinoshita, Taku Shinoda, Masahiro Nishizaki, Yasuhiro Shiraki, Katsuya Hirai, Yuji Kichikawa, Yoshiko Tsushima, Kenji Shinkai, Masaharu Komura, Naoyuki Yoshida, Kazuo Kido, Yasutoshi Kakeya, Hiroshi Uemura, Naoto Kadota, Junichi Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) |
| title | Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) |
| title_full | Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) |
| title_fullStr | Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) |
| title_full_unstemmed | Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) |
| title_short | Correction: A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) |
| title_sort | correction: a multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with covid-19 (candle study) |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9733017/ https://www.ncbi.nlm.nih.gov/pubmed/36482439 http://dx.doi.org/10.1186/s12916-022-02695-5 |
| work_keys_str_mv | AT kinoshitataku correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT shinodamasahiro correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT nishizakiyasuhiro correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT shirakikatsuya correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT hiraiyuji correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT kichikawayoshiko correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT tsushimakenji correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT shinkaimasaharu correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT komuranaoyuki correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT yoshidakazuo correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT kidoyasutoshi correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT kakeyahiroshi correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT uemuranaoto correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy AT kadotajunichi correctionamulticenterdoubleblindrandomizedparallelgroupplacebocontrolledstudytoevaluatetheefficacyandsafetyofcamostatmesilateinpatientswithcovid19candlestudy |